Zhengyang Li
About Zhengyang
Zhengyang focuses on capital markets and relevant merger & acquisitions transactions and compliance matters.
Representative matters:
Capital Markets
- Seres in its HK$14.28 billion initial public offering of H shares
- MetaLight Inc. in its HK$242.35 million initial public offering
- Zenergy in its HK$1 billion global initial public offering
- BrainAurora Medical Technology in its HK$538 million initial public offering and listing on the HKEX
- Gracell Biotechnologies on its private placement financing of up to $150 million
- ImmuneOnco Biopharmaceuticals on its HK$319 million global initial public offering and listing on the HKEX
- Bitdeer Technologies Group in its US$1.18 billion merger with Blue Safari (SPAC) and deSPAC listing on Nasdaq
- Laekna in its HK$791 million (US$101 million) initial public offering on HKEX
- YH Entertainment, the largest artist management company in China, on its HK$490 million IPO on HKEX
- Cryofocus Medtech in its HK$210 million ($27 million) initial public offering of 11,110,000 H Shares on the HKEX
- TI Cloud, a cloud-native customer contact solution provider, on its HK$559.4 million (US$71.7 million) IPO and listing on HKEX
Admissions and credentials
- New York
Get In Touch
Location
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.